| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1463-1326.2001.00030.X |
| P698 | PubMed publication ID | 11685825 |
| P2093 | author name string | Finegood DT | |
| Topp BG | |||
| P2860 | cites work | Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes | Q33639061 | ||
| The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus | Q33853759 | ||
| The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus | Q33891620 | ||
| Islet growth and development in the adult | Q33928181 | ||
| Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction | Q33936971 | ||
| Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal | Q34147299 | ||
| Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships | Q35883220 | ||
| Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes | Q35923385 | ||
| Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration | Q36899584 | ||
| Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose | Q37006231 | ||
| Assessment of insulin sensitivity in vivo | Q39816379 | ||
| Extraction of Insulin by Liver | Q39927378 | ||
| The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus | Q40992063 | ||
| Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. | Q41015653 | ||
| Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells | Q41028530 | ||
| Thiazolidinediones in the treatment of insulin resistance and type II diabetes | Q41217443 | ||
| Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia | Q41429346 | ||
| Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness | Q42435292 | ||
| Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. | Q42436119 | ||
| Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. | Q42466929 | ||
| Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance | Q42496873 | ||
| Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. | Q42525273 | ||
| Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus | Q42527473 | ||
| Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats | Q42545275 | ||
| Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death | Q43596005 | ||
| Insulin secretion in insulin-resistant women with a history of gestational diabetes | Q43816476 | ||
| Pathogenesis of NIDDM. A balanced overview | Q43832606 | ||
| A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study | Q44029398 | ||
| Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects | Q44243249 | ||
| Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects | Q44686546 | ||
| Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. | Q48685670 | ||
| Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. | Q48794672 | ||
| A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. | Q51581635 | ||
| Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis. | Q51593414 | ||
| Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis. | Q51594986 | ||
| Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. | Q51598262 | ||
| Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. | Q51600940 | ||
| Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. | Q51602007 | ||
| Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. | Q51609403 | ||
| A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. | Q52073338 | ||
| Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. | Q52348002 | ||
| Beta-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. | Q52593585 | ||
| Insulin resistance and compensatory insulin secretion in middle-aged persons with hypertriglyceridemia. | Q53765226 | ||
| Pathogenic factors responsible for glucose intolerance in patients with NIDDM | Q54256761 | ||
| Effect of heparin on insulin-glucose interactions measured by the minimal model technique: Implications for reproducibility using this method | Q58037322 | ||
| P304 | page(s) | S20-7 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
| P1476 | title | Beta-cell deterioration--prospects for reversal or prevention | |
| P478 | volume | 3 Suppl 1 |
| Q37215420 | Beta-cell failure in type 2 diabetes mellitus |
| Q35852835 | Beta-cell mass plasticity in type 2 diabetes. |
| Q36198965 | Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes |
| Q45045299 | Metabolic adaptations to chronic glucose infusion in rats |
| Q34655565 | Molecular insights into insulin action and secretion |
| Q35989381 | Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus |
| Q34750027 | Therapeutic Approaches for Preserving or Restoring Pancreatic β-Cell Function and Mass. |
| Q33558395 | β-cell mass in people with type 2 diabetes |
Search more.